SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: KEN HOFFMAN who wrote (673)5/11/1998 1:28:00 PM
From: James Perry  Respond to of 834
 
Gee, this sure reads like a bunch of wimps on this thread. The name of this game is risk taking in hopes of profit. I bought at 3.5 and was beginning to think I never would get an opportunity to acquire more at a price anywhere close. This is a good little company, and I think they will make it. I can be patient.



To: KEN HOFFMAN who wrote (673)5/11/1998 1:33:00 PM
From: fred woodall  Respond to of 834
 
Texas Biotech downgraded by PaineWebber to neutral.
I've deleted TBX from my server if that will answer your question.



To: KEN HOFFMAN who wrote (673)5/11/1998 1:45:00 PM
From: Brander  Read Replies (1) | Respond to of 834
 
Ken, it depends on how long you want to wait. TXB is dead in the water for now. They certainly could recover, but it is going to take
months. I think the minimum time it will take the FDA to even blink at Novastan again is 6 months. I would really like to know what problem the FDA had with the submission. It must have been significant, because a medication that coveres the niche Novastan was supposed to is greatly needed.

Brad


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News